+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pulmonary Embolism Therapeutics Market 2019-2023 - Product Image

Global Pulmonary Embolism Therapeutics Market 2019-2023

  • ID: 4771139
  • Report
  • Region: Global
  • 119 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • MORE
About this market

The increasing awareness programs and campaigns are expected to trigger the pulmonary embolism therapeutics market growth during the forecast period. The increasing awareness campaigns will improve the awareness of the severity of blood clots, resulting in various patients undergoing diagnosis and treatment on time. Such growing popularity will eventually boost the market growth in the forthcoming years. The analysts have predicted that the pulmonary embolism therapeutics market will register a CAGR of 9% by 2023.

Market Overview

Increasing oral anticoagulants

Traditionally, the global pulmonary embolism therapeutics market was dominated by Heparin, an anticoagulant drug, which is administered through parenteral route. The market also had various other anticoagulant drugs that were approved; however, most of these drugs were administered through invasive routes. These drugs require no or very less patient monitoring unlike their predecessors from the parenteral route. This will further aid to the popularity of oral anticoagulants.

Preference for alternative therapies

The increasing popularity and the advances in alternative treatment methods are expected to pose a major challenge to the growth of the global pulmonary embolism therapeutics market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the pulmonary embolism therapeutics market during 2019-2023, view the full report.

Competitive Landscape

The market appears to be highly concentrated and with the presence of a few market players. Several vendors in the market are also entering into strategic alliances to manufacture the drugs so that they could concentrate on their core competencies such as research. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • MORE
ART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY ROA
  • Market segmentation by RoA
  • Comparison by RoA
  • Oral - Market size and forecast 2018-2023
  • Parenteral - Market size and forecast 2018-2023
  • Market opportunity by RoA
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Increasing research on anticoagulant antidotes
  • Strategic alliances
  • Extensive research on regenerative therapies
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: RoA - Market share 2018-2023 (%)
Exhibit 18: Comparison by RoA
Exhibit 19: Oral - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Oral - Year-over-year growth 2019-2023 (%)
Exhibit 21: Parenteral - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Parenteral - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by RoA
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Europe
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Asia
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Boehringer Ingelheim International GmbH - Vendor overview
Exhibit 48: Boehringer Ingelheim International GmbH - Business segments
Exhibit 49: Boehringer Ingelheim International GmbH - Organizational developments
Exhibit 50: Boehringer Ingelheim International GmbH - Geographic focus
Exhibit 51: Boehringer Ingelheim International GmbH - Segment focus
Exhibit 52: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 53: Boehringer Ingelheim International GmbH - Key customers
Exhibit 54: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 55: Bristol-Myers Squibb Co. - Business segments
Exhibit 56: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 57: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 58: Bristol-Myers Squibb Co. - Key offerings
Exhibit 59: Bristol-Myers Squibb Co. - Key customers
Exhibit 60: Daiichi Sankyo Co. Ltd. - Vendor overview
Exhibit 61: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 62: Daiichi Sankyo Co. Ltd. - Organizational developments
Exhibit 63: Daiichi Sankyo Co. Ltd. - Geographic focus
Exhibit 64: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 65: Daiichi Sankyo Co. Ltd. - Key customers
Exhibit 66: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 67: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 68: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 69: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 70: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 71: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 72: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 73: Johnson & Johnson Services Inc. - Vendor overview
Exhibit 74: Johnson & Johnson Services Inc. - Business segments
Exhibit 75: Johnson & Johnson Services Inc. - Organizational developments
Exhibit 76: Johnson & Johnson Services Inc. - Geographic focus
Exhibit 77: Johnson & Johnson Services Inc. - Segment focus
Exhibit 78: Johnson & Johnson Services Inc. - Key offerings
Exhibit 79: Johnson & Johnson Services Inc. - Key customers
Exhibit 80: Validation techniques employed for market sizing
Exhibit 81: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • MORE
Global Pulmonary Embolism Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global pulmonary embolism therapeutics market: Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann-La Roche Ltd., and Johnson & Johnson Services Inc.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the extensive research on regenerative therapies.”

According to the report, one of the major drivers for this market is the increasing oral anticoagulants.

Further, the report states that one of the major factors hindering the growth of this market is the difficulty in diagnosis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.
Note: Product cover images may vary from those shown
Adroll
adroll